Development of a suite of proteins, antibodies, and assays for use in Parkinson’s Disease research and an antibody to treat the disease.
STRESSMARQ BIOSCIENCES INC.
13 records totalling $1,150,873.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $1,150,873 | 13 records |
Records
This project will develop techniques to generate active, soluble oligomeric constructs of prion-like proteins relevant in neurological disease, including Tau, alpha synuclein and Abeta, using a variet...
This project aims to generate materials that can be used in an protein-based amplification assay that can determine the presence of prion-like aggregates in biological samples.
Stressmarq Biosciences Inc. Has developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research. The company aims to increase it's export of these to fi...
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a...
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a...
Stressmarq Biosciences Inc. Has developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research. The company aims to increase it's export of these to fi...
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a...